Skip to main content

Advertisement

Log in

Alteration of the Expression of CD4 Isoforms in Oral Epithelia and Saliva from Patients with Oral Lichen Planus

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

An Erratum to this article was published on 18 October 2007

Abstract

Oral lichen planus (OLP) is a chronic inflammatory mucosal disease that cell-mediated immunological mechanisms are involved in pathogenesis. The objective of this study was to investigate the expression of CD44 isoforms including CD44s, CD44v5, and CD44v6 in biopsy specimens and saliva from OLP patients. Thirty-one OLP patients and 30 healthy subjects were enrolled in this study. Immunohistochemical methods were used to detect the expression of CD44 isoforms in oral epithelia, and enzyme-linked immunosorbent assay (ELISA) was performed to measure levels of salivary CD44 isoforms. Our results demonstrated that expression of CD44v6 in oral epithelia from OLP patients was significantly decreased in comparison to controls (p = 0.021). Levels of salivary CD44s and CD44v5 from OLP patients were significantly higher than those from controls (p = 0.007 and p = 0.002, respectively). In summary, our findings provided additional evidence that the pathological stress, such as chronic inflammation, altered the expression of CD44 isoforms in oral epithelia and saliva of OLP patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting, Part 1, viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:40–51.

    Article  PubMed  Google Scholar 

  2. Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med. 1998;9:86–22.

    Article  PubMed  CAS  Google Scholar 

  3. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand. 2001;59:174–7.

    Article  PubMed  CAS  Google Scholar 

  4. Sugerman PB, Savage NW, Walsh IJ, Zhao ZZ, Zhou XJ, Khan A, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med. 2002;13:351–67.

    Google Scholar 

  5. Simark-Mattsson C, Bergenholtz G, Jontell M, Eklund C, Seymour GJ, Sugerman PB, et al. Distribution of interleukin-2,-4,-10, tumour necrosis factor-. a. and transforming growth factor-. b. mRNAs in oral lichen planus. Arch Oral Biol. 1999;44:499–07.

    Article  PubMed  CAS  Google Scholar 

  6. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. Th1 cytokines in oral lichen planus. J Oral Pathol Med. 2003;32:77–3.

    Article  PubMed  CAS  Google Scholar 

  7. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F. A comparison of the pro-inflammatory, NF-. k. B-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients. Clin Immunol. 2005;114:278–83.

    Article  PubMed  CAS  Google Scholar 

  8. Thongprasom K, Dhanuthai K, Sarideechaigul W, Chaiyarit P, Chaimusig M. Expression of TNF-. a. in oral lichen planus treated with fluocinolone acetonide 0.1%. J Oral Pathol Med. 2006;35:161–6.

    Article  PubMed  CAS  Google Scholar 

  9. Bascones C, Gonzalez-Moles MA, Esparza G, Bravo M, Acevedo A, Gil-Montoya JA, et al. Apoptosis and cell cycle arrest in oral lichen planus: hypothesis on their possible influence on its malignant transformation. Arch Oral Biol. 2005;50:873–81.

    Article  PubMed  CAS  Google Scholar 

  10. Kim SG, Chae CH, Cho BO, Kim HN, Kim HJ, Kim IS, et al. Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4. J Oral Pathol Med. 2006;35:37–45.

    Article  PubMed  CAS  Google Scholar 

  11. Farthing PM, Matear P, Crunchley AT. The activation of Langerhans cells in oral lichen planus. J Oral Pathol Med. 1990;19:81–5.

    Article  PubMed  CAS  Google Scholar 

  12. Santoro A, Majorana A, Roversi L, Gentili F, Marrelli S, Vermi W. Recruitment of dendritic cells in oral lichen planus. J Pathol. 2005;205:426–34.

    Article  PubMed  Google Scholar 

  13. Konter U, Kellner I, Hoffmeister B, Sterry W. Induction and up-regulation of adhesion receptors in oral and dermal lichen planus. J Oral Pathol Med. 1990;19:459–63.

    Article  PubMed  CAS  Google Scholar 

  14. Ramirez-Amador V, Dekker NP, Lozada-Nur F, Mirowski GW, MacPhail LA, Regezi JA. Altered interface adhesion molecules in oral lichen planus. Oral Dis. 1996;2:188–92.

    Article  PubMed  CAS  Google Scholar 

  15. Regezi JA, Dekker NP, MacPhail LA, Lozada-Nur F, McCalmont TH. Vascular adhesion molecules in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:682–90.

    Article  PubMed  CAS  Google Scholar 

  16. Chaiyarit P, Ma N, Hiraku Y, Pinlaor S, Yongvanit P, Jintakanon D, et al. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci. 2005;96:553–9.

    Article  PubMed  CAS  Google Scholar 

  17. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 1992;89:12160–4.

    Article  PubMed  CAS  Google Scholar 

  18. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell. 1989;56:1057–62.

    Article  PubMed  CAS  Google Scholar 

  19. Goldstein LA, Butcher EC. Indentification of mRNA that encodes an alternative form of H-CAM (CD44) in lymphoid and nonlymphoid tissues. Immunogenetics. 1990;32:389–97.

    Article  PubMed  CAS  Google Scholar 

  20. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 1991;10:343–8.

    PubMed  CAS  Google Scholar 

  21. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, et al. Activated human lymphocytes and aggressive non-Hodgkin’s lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med. 1993;177:897–04.

    Article  PubMed  CAS  Google Scholar 

  22. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1301–13.

    Article  Google Scholar 

  23. Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol. 1992;116:817–25.

    Article  PubMed  CAS  Google Scholar 

  24. Ehnis T, Dieterich W, Bauer M, Lampe B, Schuppan D. A chondroitin/dermatan sulfate form of CD44 is a receptor for collagenXIV (undulin). Exp Cell Res. 1996;229:388–97.

    Article  PubMed  CAS  Google Scholar 

  25. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 1996;271:509–12.

    Article  PubMed  CAS  Google Scholar 

  26. Jones M, Tussey L, Athanasou N, Jackson DG. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J Biol Chem. 2000;275:7964–74.

    Article  PubMed  CAS  Google Scholar 

  27. Murakami S, Miyake K, June CH, Kincade PW, Hodes RJ. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J Immunol. 1990;145:3618–27.

    PubMed  CAS  Google Scholar 

  28. Ariel A, Novick D, Rubinstein M, Dinarello CA, Lider O, Hershkoviz R. IL-12 and IL-18 induce MAP kinase dependent adhesion of T cells to extracellular matrix components. J Leukoc Biol. 2002;72:192–8.

    PubMed  CAS  Google Scholar 

  29. Reid SD, Pockley AG. Cytokine regulation of CD44 expression on rat intestinal epithelial cells. Immunol Invest. 2000;29:271–86.

    PubMed  CAS  Google Scholar 

  30. Gee K, Lim W, Ma W, Nandan D, Diaz-Mitoma F, Kozlowski M. Differential role of CD44 expression by LPS and TNF-. a. in human monocytic cells: distinct involvement of C-jun-N-terminal kinase in LPS-induced CD44 expression. J Immunol. 2002;169:5660–72.

    PubMed  CAS  Google Scholar 

  31. Cichy J, Pure E. The liberation of CD44. J Cell Biol. 2003;161:839–43.

    Article  PubMed  CAS  Google Scholar 

  32. Kawano T, Yanoma S, Nakamura Y, Shiono O, Kokatu T, Kubota A, et al. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer. Am J Otolaryngol. 2005;26:308–13.

    Article  PubMed  CAS  Google Scholar 

  33. Katoh S, Matsubara Y, Taniguchi H, Fukushima K, Mukae H, Kadota J, et al. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis. Clin Exp Immunol. 2001;126:545–50.

    Article  PubMed  CAS  Google Scholar 

  34. Fuchs S, Rolauffs B, Arndt S, Tibesku CO, Prehm P. CD44H and the isoforms CD44v5 and CD44v6 in the synovial fluid of the osteoarthritic human knee joint. Osteoarthritis Cartilage. 2003;11:839–44.

    Article  PubMed  CAS  Google Scholar 

  35. Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ. Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2005;3:735–9.

    Article  Google Scholar 

  36. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, et al. Membrane type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol. 2001;153:893–04.

    Article  PubMed  CAS  Google Scholar 

  37. Sherman L, Wainwright D, Ponta H, Herrlich P. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev. 1998;12:1058–71.

    PubMed  CAS  Google Scholar 

  38. Ghaffari S, Smadja-Joffe F, Ooostendorp R, Levelsque JP, Dougherty G, Eaves A, et al. CD44 isoforms in normal and leukemic hematopoiesis. Exp Hematol. 1999;27:978–93.

    Article  PubMed  CAS  Google Scholar 

  39. Gunthert U, Schwarzler C, Wittig B, Laman J, Ruiz P, Stauder R, et al. Functional involvement of CD44, a family of cell adhesion molecules, in immune response, tumour progression and haematopoiesis. Adv Exp Med Biol. 1998;451:43–9.

    PubMed  CAS  Google Scholar 

  40. Stoop R, Gal I, Glant TT, McNeish JD, Mikecz K. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions. Eur J Immunol. 2002;32:2532–42.

    Article  PubMed  CAS  Google Scholar 

  41. McKallip RJ, Do Y, Fisher MT, Robertson JL, Nagarkatti PS, Nagarkatti M. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int Immunol. 2002;14:1015–26.

    Article  PubMed  CAS  Google Scholar 

  42. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med. 2001;7:213–21.

    Article  PubMed  CAS  Google Scholar 

  43. Yamada M, Nakano K, Yasumoto K, Tanaka Y. CD44: Functional relevance to inflammation and malignancy. Histol Histopathol. 2002;17:945–50.

    Google Scholar 

  44. MacKay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Gunthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol. 1994;124:71–82.

    Article  PubMed  CAS  Google Scholar 

  45. Levesque MC, Haynes BF. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol. 1996;156:1557–65.

    PubMed  CAS  Google Scholar 

  46. Teder Vandivier PRW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, et al. Resolution of lung inflammation by CD44. Science. 2002;296:155–8.

    Article  Google Scholar 

  47. Haberhauer G, Kittl EM. Soluble CD44 isoform variant-5 (sCD44v5): a new serum marker in rheumatoid arthritis. J Rheumatol. 1998;25:1442–4.

    PubMed  CAS  Google Scholar 

  48. Schlosser W, Gansauge F, Schlosser S, Gansauge S, Beger HG. Low serum levels of CD44, CD44v6, and neopterin indicate immune dysfunction in chronic pancreatitis. Pancreas. 2001;23:335–40.

    Article  PubMed  CAS  Google Scholar 

  49. Pfister K, Wittig BM, Mueller-Molaian I, Remberger K, Zeitz M, Stallmach A. Decreased CD44v6 expression in lamina propria lymphocytes of patients with inflammatory bowel disease. Exp Mol Pathol. 2001;71:186–93.

    Article  PubMed  CAS  Google Scholar 

  50. Neppelberg E, Loro LL, Oijordsbakken G, Johannessen AC. Altered CD40 and E-cadherin expression- putative role in oral lichen planus. J Oral Pathol Med. 2007;36:153–60.

    Article  PubMed  CAS  Google Scholar 

  51. Thongprasom K, Luengvisut P, Wongwatanakit A, Boonjatturus C. Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med. 2003;32:315–22.

    Article  PubMed  CAS  Google Scholar 

  52. Denhardt DT, Noda M, O’Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest. 2001;107:1055–61.

    Article  PubMed  CAS  Google Scholar 

  53. Orian-Rousseau V, Morrison H, Matzke A, Kastilan T, Pace G, Herrlich P, et al. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol Biol Cell. 2007;18:76–83.

    Article  PubMed  CAS  Google Scholar 

  54. Sutinen M, Kainulainen T, Hurskainen T, Vesteriund E, Alexander JP, Overall CM, et al. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer. 1998;77:2239–45.

    PubMed  CAS  Google Scholar 

  55. Zhou XJ, Sugerman PB, Savage NW, Walsh LJ. Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol. 2001;28:72–82.

    Article  PubMed  CAS  Google Scholar 

  56. Mikecz K, Dennis K, Shi M, Kim JH. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum. 1999;42:659–68.

    Article  PubMed  CAS  Google Scholar 

  57. Cairns AP, Crockard AD, McConnell JR, Courtney PA, Bell AL. Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity. Ann Rheum Dis. 2001;60:950–5.

    Article  PubMed  CAS  Google Scholar 

  58. Reinisch W, Heider KH, Oberhuber G, Dejaco C, Mullner M, Adolf GR, et al. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn’s disease. GUT. 1998;43:375–82.

    Article  PubMed  CAS  Google Scholar 

  59. Rosenberg WMC, Prince C, Kaklamanis L, Fox SB, Jackson DG, Simmons DL, et al. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn’s disease. Lancet. 1995;345:1205–9.

    Article  PubMed  CAS  Google Scholar 

  60. Kemppainen T, Tammi R, Tammi M, Agren U, Julkunen R, Bohm J, et al. Elevated expression of hyaluronan and its CD44 receptor in the duodenal mucosa of celiac patients. Histopathology. 2005;46:64–72.

    Article  PubMed  CAS  Google Scholar 

  61. Levesque MC, Mackin DA, Fleming JA, St Clair EW. Serum levels of soluble CD44 in Primary Sjögren’s syndrome. J Rheumatol. 2000;27:1444–9.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This research work was supported by The Thailand Research Fund (# MRG4880152). The authors would like to express our thanks to Dr. Wichian Chowsrikul for providing biopsy specimens used as positive controls and to Dr. Richard L. Gregory for his contribution on reviewing this manuscript. The authors also thank the Research Unit in Oral Diseases, Faculty of Dentistry, Chulalongkorn University for previous support. Finally, we would like to thank the staff of the Department of Oral Diagnosis, Faculty of Dentistry, Khon Kaen University and the staff of the Departments of Oral Medicine and Oral Pathology, Faculty of Dentistry, Chulalongkorn University for their assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ponlatham Chaiyarit.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s10875-007-9136-5

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaiyarit, P., Thongprasom, K., Satayut, S. et al. Alteration of the Expression of CD4 Isoforms in Oral Epithelia and Saliva from Patients with Oral Lichen Planus. J Clin Immunol 28, 26–34 (2008). https://doi.org/10.1007/s10875-007-9128-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-007-9128-5

Keywords

Navigation